PL401195A1 - Sposób wytwarzania witaminy K2 w formie MK-7 - Google Patents

Sposób wytwarzania witaminy K2 w formie MK-7

Info

Publication number
PL401195A1
PL401195A1 PL401195A PL40119512A PL401195A1 PL 401195 A1 PL401195 A1 PL 401195A1 PL 401195 A PL401195 A PL 401195A PL 40119512 A PL40119512 A PL 40119512A PL 401195 A1 PL401195 A1 PL 401195A1
Authority
PL
Poland
Prior art keywords
hexaprenyl
formula
alkylation reaction
halide
vitamin
Prior art date
Application number
PL401195A
Other languages
English (en)
Inventor
Krzysztof Krajewski
Andrzej Kutner
Regina Gutowska
Jerzy Winiarski
Marek Kubiszewski
Łukasz Jedynak
Marek Napiórkowski
Jacek Morzycki
Stanisław Witkowski
Aneta Baj
Piotr Wałejko
Original Assignee
Instytut Farmaceutyczny
Vitasynth Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50442211&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL401195(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Instytut Farmaceutyczny, Vitasynth Spółka Z Ograniczoną Odpowiedzialnością filed Critical Instytut Farmaceutyczny
Priority to PL401195A priority Critical patent/PL401195A1/pl
Priority to US14/435,260 priority patent/US9828323B2/en
Priority to LTEP13792773.7T priority patent/LT2917171T/lt
Priority to JP2015536739A priority patent/JP2015531404A/ja
Priority to CN201380063042.3A priority patent/CN104903282B/zh
Priority to DK13792773.7T priority patent/DK2917171T3/en
Priority to TR2018/18397T priority patent/TR201818397T4/tr
Priority to AU2013330517A priority patent/AU2013330517B2/en
Priority to RU2015117398A priority patent/RU2015117398A/ru
Priority to MX2015004618A priority patent/MX2015004618A/es
Priority to ES13792773T priority patent/ES2701808T3/es
Priority to PCT/PL2013/000132 priority patent/WO2014058330A2/en
Priority to KR1020157012230A priority patent/KR102229841B1/ko
Priority to EP13792773.7A priority patent/EP2917171B1/en
Priority to CA2888010A priority patent/CA2888010C/en
Priority to BR112015008021A priority patent/BR112015008021A2/pt
Priority to PL13792773T priority patent/PL2917171T3/pl
Publication of PL401195A1 publication Critical patent/PL401195A1/pl
Priority to TNP2015000137A priority patent/TN2015000137A1/fr
Priority to IL238199A priority patent/IL238199A/en
Priority to CY191100035T priority patent/CY1121117T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/527—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings
    • C07C49/553—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C07C315/04—Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01—Preparation of ethers
    • C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Sposób wytwarzania witaminy K2 w formie MK-7 polega na dołączeniu łańcucha heksaprenylowego o konfiguracji "all-trans" do pochodnej monoprenylowej menadiolu zgodnie ze strategią "1+6". Karboanion ?-sulfonylowy generowany z zabezpieczonego monoprenylomenadiolu o wzorze (II) pod działaniem silnej zasady metaloorganicznej poddaje się in situ reakcji alkilowania halogenkiem heksaprenylu o wzorze (VII), w którym X oznacza atom fluorowca, korzystnie brom, jeden z podstawników Z' i Z" oznacza atom wodoru, a drugi grupę fenylosulfonylową -SO2Ph, przy czym halogenek heksaprenylu otrzymuje się w wyniku połączenia dwu jednostek triprenylowych w reakcji alkilowania, z, lub bez wyodrębniania związków pośrednich.
PL401195A 2012-10-12 2012-10-12 Sposób wytwarzania witaminy K2 w formie MK-7 PL401195A1 (pl)

Priority Applications (20)

Application Number Priority Date Filing Date Title
PL401195A PL401195A1 (pl) 2012-10-12 2012-10-12 Sposób wytwarzania witaminy K2 w formie MK-7
PL13792773T PL2917171T3 (pl) 2012-10-12 2013-10-11 Sposób wytwarzania witaminy K<sub>2</sub> w formie MK-7
RU2015117398A RU2015117398A (ru) 2012-10-12 2013-10-11 Способ получения мк-7 типа витамина к2
ES13792773T ES2701808T3 (es) 2012-10-12 2013-10-11 Procedimiento de preparación de vitamina K2 del tipo MK-7
JP2015536739A JP2015531404A (ja) 2012-10-12 2013-10-11 ビタミンｋ２のｍｋ−７型の調整方法
CN201380063042.3A CN104903282B (zh) 2012-10-12 2013-10-11 用于制备mk-7类型的维生素k2的方法
DK13792773.7T DK2917171T3 (en) 2012-10-12 2013-10-11 METHOD FOR PREPARING MK-7 TYPE OF K2 VITAMIN
TR2018/18397T TR201818397T4 (tr) 2012-10-12 2013-10-11 Mk-7 tipi k2 vitamininin hazirlanmasina yönelik proses.
AU2013330517A AU2013330517B2 (en) 2012-10-12 2013-10-11 Process for preparation of MK-7 type of vitamin K2
US14/435,260 US9828323B2 (en) 2012-10-12 2013-10-11 Process for preparation of MK-7 type of vitamin K2
MX2015004618A MX2015004618A (es) 2012-10-12 2013-10-11 Proceso de preparacion de vitamina k2 del tipo mk-7.
LTEP13792773.7T LT2917171T (lt) 2012-10-12 2013-10-11 Vitamino k2 mk-7 tipo gamybos būdas
PCT/PL2013/000132 WO2014058330A2 (en) 2012-10-12 2013-10-11 Process for preparation of mk-7 type of vitamin k2
KR1020157012230A KR102229841B1 (ko) 2012-10-12 2013-10-11 비타민 k2의 mk-7 타입의 제조를 위한 방법
EP13792773.7A EP2917171B1 (en) 2012-10-12 2013-10-11 Process for preparation of mk-7 type of vitamin k2
CA2888010A CA2888010C (en) 2012-10-12 2013-10-11 Process for preparation of mk-7 type of vitamin k2
BR112015008021A BR112015008021A2 (pt) 2012-10-12 2013-10-11 processo para preparação do tipo mk-7 de vitamina k
TNP2015000137A TN2015000137A1 (en) 2012-10-12 2015-04-10 Process for preparation of mk-7 type of vitamin k2
IL238199A IL238199A (en) 2012-10-12 2015-04-12 A process for making vitamin k2 type MK-7
CY191100035T CY1121117T1 (el) 2012-10-12 2019-01-14 Μεθοδος για την παρασκευη βιταμινης κ2 του τυπου μκ-7

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL401195A PL401195A1 (pl) 2012-10-12 2012-10-12 Sposób wytwarzania witaminy K2 w formie MK-7

Publications (1)

Publication Number Publication Date
PL401195A1 true PL401195A1 (pl) 2014-04-14

Family

ID=50442211

Family Applications (2)

Application Number Title Priority Date Filing Date
PL401195A PL401195A1 (pl) 2012-10-12 2012-10-12 Sposób wytwarzania witaminy K2 w formie MK-7
PL13792773T PL2917171T3 (pl) 2012-10-12 2013-10-11 Sposób wytwarzania witaminy K<sub>2</sub> w formie MK-7

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL13792773T PL2917171T3 (pl) 2012-10-12 2013-10-11 Sposób wytwarzania witaminy K<sub>2</sub> w formie MK-7

Country Status (19)

Country Link
US (1) US9828323B2 (pl)
EP (1) EP2917171B1 (pl)
JP (1) JP2015531404A (pl)
KR (1) KR102229841B1 (pl)
CN (1) CN104903282B (pl)
AU (1) AU2013330517B2 (pl)
BR (1) BR112015008021A2 (pl)
CA (1) CA2888010C (pl)
CY (1) CY1121117T1 (pl)
DK (1) DK2917171T3 (pl)
ES (1) ES2701808T3 (pl)
IL (1) IL238199A (pl)
LT (1) LT2917171T (pl)
MX (1) MX2015004618A (pl)
PL (2) PL401195A1 (pl)
RU (1) RU2015117398A (pl)
TN (1) TN2015000137A1 (pl)
TR (1) TR201818397T4 (pl)
WO (1) WO2014058330A2 (pl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL424875A1 (pl) * 2018-03-12 2019-09-23 Vitasynth Spółka Z Ograniczoną Odpowiedzialnością Sposób syntezy witaminy K2

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0817528D0 (en) 2008-09-24 2008-10-29 Syntavit As Process
US11407704B2 (en) 2018-04-06 2022-08-09 Siec Badawcza Lukasiewicz-Instytut Chemii Przemyslowej Imienia Profesora Ignacego Moscickiego Process of vitamin K2 derivatives preparation
WO2021071372A1 (en) 2019-10-07 2021-04-15 Sieć Badawcza Łukasiewicz - Instytut Farmaceutyczny Process of vitamin k2 derivatives preparation
PL243187B1 (pl) 2020-07-16 2023-07-10 Vitasynth Spolka Z Ograniczona Odpowiedzialnoscia Sposób i związki pośrednie do otrzymywania menachinonu MK-7
CN113403348B (zh) * 2021-06-18 2022-03-22 山东润德生物科技有限公司 一种维生素k2的制备方法
WO2023031841A1 (en) * 2021-09-03 2023-03-09 Synergia Life Sciences Pvt. Ltd. A process for the stereospecific synthesis of vitamin k2 and its intermediates
CN114149314B (zh) * 2021-11-26 2024-05-28 安徽先和医药研究有限公司 Vk2的合成方法
WO2024013633A1 (en) * 2022-07-11 2024-01-18 Synergia Life Sciences Pvt. Ltd. Process for the synthesis of vitamin k2
CN117867044B (zh) * 2023-12-27 2024-07-30 杭州微远生物科技有限公司 一种维生素mk-4的生物酶法制备工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1091680A (en) 1976-10-19 1980-12-16 Shinji Terao Method for production of quinones
FR2435466A1 (fr) * 1978-08-02 1980-04-04 Kuraray Co Derives de l'hydroquinone et leur procede de preparation
US8414565B2 (en) * 2002-12-16 2013-04-09 The Ohio State University Parametric model based ablative surgical systems and methods
FR2925908A1 (fr) * 2007-12-27 2009-07-03 Bmuestar Silicones France Sas Composition reticulable/polymerisable par voie cationique comprenant un borate de iodonium et degageant une odeur acceptable
DE202008008134U1 (de) 2008-06-17 2009-06-25 Bischof + Klein Gmbh & Co. Kg Seitenfaltenbeutel
GB0817528D0 (en) 2008-09-24 2008-10-29 Syntavit As Process
GB201004876D0 (en) * 2010-03-23 2010-05-05 Syntavit As Process for the preparation of vitamin K2

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL424875A1 (pl) * 2018-03-12 2019-09-23 Vitasynth Spółka Z Ograniczoną Odpowiedzialnością Sposób syntezy witaminy K2

Also Published As

Publication number Publication date
JP2015531404A (ja) 2015-11-02
AU2013330517A1 (en) 2015-05-28
KR20150091469A (ko) 2015-08-11
DK2917171T3 (en) 2019-01-07
AU2013330517B2 (en) 2017-07-20
KR102229841B1 (ko) 2021-03-22
IL238199A (en) 2017-04-30
TR201818397T4 (tr) 2019-01-21
CY1121117T1 (el) 2019-12-11
PL2917171T3 (pl) 2019-04-30
US20150291498A1 (en) 2015-10-15
CN104903282B (zh) 2018-10-23
US9828323B2 (en) 2017-11-28
WO2014058330A3 (en) 2014-06-19
WO2014058330A2 (en) 2014-04-17
EP2917171A2 (en) 2015-09-16
MX2015004618A (es) 2016-06-10
TN2015000137A1 (en) 2016-10-03
CN104903282A (zh) 2015-09-09
BR112015008021A2 (pt) 2017-07-04
CA2888010A1 (en) 2014-04-17
EP2917171B1 (en) 2018-11-07
ES2701808T3 (es) 2019-02-26
RU2015117398A (ru) 2016-11-27
CA2888010C (en) 2021-05-25
LT2917171T (lt) 2019-01-25

Similar Documents

Publication Publication Date Title
PL401195A1 (pl) Sposób wytwarzania witaminy K2 w formie MK-7
JOP20210065A1 (ar) عملية لتحضير 5- فلورو-1h- بيرازولوبيريدينات مستبدلة
CO6852084A2 (es) Nuevos compuestos sustituidos con halógeno
MX2015002616A (es) Sintesis de bis(fluorosulfonil)imida.
BR112013018975A2 (pt) processo para o preparo de 4-amino-5-fluoro-3-halo-6-(substituído)picolinatos
NZ734535A (en) Process of producing cycloalkylcarboxamido-indole compounds
UY31367A1 (es) Derivados de nicotinamida, su preparacion y su aplicacion en terapeutica
AR067355A1 (es) Procesos para la preparacion de pirazoles
PH12015502684B1 (en) New compounds having triple activities of thrombolysis, antithrombotic and radical scavenging, and synthesis, nano-structure and use thereof
MX343869B (es) Compuestos, composiciones y artículos fotocromáticos.
AR085052A1 (es) Metodos para producir un compuesto profarmaco inhibidor de la union al vih e intermediarios
UY31577A1 (es) Proceso para la preparacion de 6-sustituido-1-(2h)-isoquinolinonas
CL2013000589A1 (es) Metodo para preparar derivados del acido 3-amino-4-(3,4,5,5-tetrasustituido)-2-oxo-piperidin-1-il)-4-butirico por reaccion entre un acido 3,4-diaminobutanoico y un acido 5-hidroxipentanoico.
IN2015DN02854A (pl)
AU2012317424A8 (en) Crystal of 5-hydroxy-1h-imidazole-4-carboxamide 3/4 hydrate, method for producing the same and crystal of 5-hydroxy-1h-imidazole-4-carboxamide hydrate
GB2523674A (en) Compounds as inhibitor of DNA double-strand break repair, methods and applications thereof
AR094706A1 (es) Proceso para producir compuesto de piridazinona y producción de sus intermediarios
UY35561A (es) Procedimiento de síntesis del 3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7- carbonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
WO2012052939A3 (en) Preparation of bicyclo[2.2.2]octan-2-one compounds
MX2012013388A (es) Metodo para fabricar 1-alquil-3-difluorometil-5-hidroxipirazoles.
SE0402462D0 (sv) New process
PH12015501840A1 (en) Production method of pyridazinone compounds
MX2015017747A (es) Proceso para producir 2-fenil-1, 3-benzoxazoles.
BR112014009013A2 (pt) método melhorado para a produção de ligandos aß rotulados por f-18
CO2023012775A2 (es) Proceso químico